Sljedeći

Auto Play

Emerging Agents in the Pipeline for Merkel Cell Carcinoma

3 Pogledi • 07/17/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play